Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NS5B polymerase inhibitors(Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H26N7O4P |
InChIKeyDGOTYTQLPLGHOO-UHFFFAOYSA-N |
CAS Registry1987906-92-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Preclinical | US | 01 Sep 2016 |